BLAINE BUCHANAN: Open Payments
NPI 1598132961 · SPARTANBURG, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$465 in 15 payments from 11 companies in 2025. Trend: 2023 $403 · 2024 $267 · 2025 $465
Food & beverage: $465
| Company | Payments | Amount |
|---|---|---|
| AtriCure, Inc. | 1 | $159 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $66 |
| Merck Sharp & Dohme LLC | 2 | $51 |
| ABIOMED | 1 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| La Jolla Pharmaceutical Company | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
Products named: ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM, Kerendia, FARXIGA, KEYTRUDA, GIAPREZA, LEQVIO, JARDIANCE, LifeVest.
Industry payments across SC — which companies pay providers there.
